Cosmos Health Inc. (COSM) vs Neuphoria Therapeutics Inc. (NEUP)
A side-by-side comparison of Cosmos Health Inc. and Neuphoria Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COSM
Cosmos Health Inc.
$0.32HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NEUP
Neuphoria Therapeutics Inc.
$3.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — COSM vs NEUP
growth of $100 · dividends reinvested · last 5yCOSM -99.6% (-66.6%/yr)NEUP -98.0% (-54.5%/yr)NEUP compounded faster over this window
COSM NEUP
COSM vs NEUP: by the numbers
- •NEUP is the larger company ($19M vs $17M market cap).
- •Both run net losses; COSM's is the smaller (-33.08% vs -1578.40% net margin).
- •NEUP grew revenue faster over the past five years (11.12% vs 5.24% CAGR).
Metrics side by side
Valuation
| Metric | COSM | NEUP |
|---|---|---|
| P/S ratio | 0.24 | 15.88 |
| P/B ratio | 0.84 | 0.76 |
Profitability
| Metric | COSM | NEUP |
|---|---|---|
| Gross margin | 10.27% | 43.54% |
| Operating margin | -24.65% | -835.53% |
| Net margin | -33.08% | -1578.40% |
| ROE | -117.98% | -75.34% |
| ROIC | -46.69% | -49.83% |
Growth (annualized)
| Metric | COSM | NEUP |
|---|---|---|
| Revenue CAGR (5Y) | 5.24% | 11.12% |
| Total return CAGR (5Y) | -68.41% | N/A |
Frequently asked
- Which has grown faster, COSM or NEUP?
- Over the past five years, NEUP grew revenue faster — COSM at a 5.24% CAGR versus NEUP at 11.12%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.